Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG
索拉非尼联合强化化疗治疗新诊断的FLT3-ITD AML:ALLG的一项随机、安慰剂对照研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023020301
Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon; Schwarer, Anthony P; Enjeti, Anoop K; D'Rozario, James; Marlton, Paula; Bilmon, Ian A; Taper, John; Cull, Gavin; Tiley, Campbell; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nick; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam; Ting, Stephen B; Fong, Chun Yew; Morris, Kirk; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H